A national biotech incubator is being set up in an Australia first following a $40 million grant from the federal government’s Medical Research Future Fund (MRFF) The incubator will be run by the Brandon Capital-managed Medical Research Commercialisation Fund (MRCF), which received the grant as part of $79 million in MRFF commercialisation grants to four… Read more »
A biotech startup focused on treating cancer has raised $5.4 million, led by mining billionaire Andrew Forrest’s Minderoo Foundation. Adelaide-based Carina Biotech will use the cash injection to develop its “CAR-T” cell therapies to treat cancers such as colorectal cancer, which is the deadliest cancer for 25-34-year-old Australians. Carina’s founding shareholders, board and management also… Read more »
The NSW government’s health department has turned once again to deep tech incubator Cicada Innovations to deliver a free training program to help aspiring biotech and medtech entrepreneurs and academics commercialise their ideas. The NSW Health Commercialisation Training Program aims to fast-track innovative ideas that will revolutionise the healthcare sector, improve patient outcomes, and provide… Read more »
Australian biotech venture Microbio announced this week that it has developed a new type of COVID-19 test with the potential to both determine if someone has the virus and also indicate whether they are infectious. The Brisbane-based startup says its InfectID-COVID-19-R test has been independently validated to identify the presence of the virus when still… Read more »
This year marks the 20th anniversary of Australia’s first ever incubator, Cicada Innovations. To date, Cicada Innovations has incubated more than 100 startups, and helped more than 300 companies raise in excess of $450 million in venture capital and government grants, create hundreds of jobs, build local manufacturing capability, file more than 500 patents and… Read more »
Emerging South Australian biotechnologies will be accelerated through a Chinese-backed AU$45 million investment fund aimed at commercialising health research for the global market. The Adelaide China Biotech Investment Fund is backed by a group of private investors based in Nanjing, China. The group is led by Mr An LuFan, Executive Director of D&R Pharmaceuticals, one… Read more »
Launching Denteric are: Melbourne Dental School Head of School Professor Mike Morgan, CSL Senior Vice President of Research Dr Andrew Nash, University of Melbourne Vice-President (Enterprise) Doron Ben-Meir, COHR CEO & Director of Research Professor Eric Reynolds, Member for Higgins Dr Katie Allen and Brandon Capital Investment Manager Ingmar Wahlqvist A new biotech company Denteric, which… Read more »
A new biotech funding program for startups working on new therapies, technologies and medical devices is offering up to $1 million in matching grants to help companies develop their ideas through to the proof of concept stage. The Biomedical Translation Bridge program is an initiative of the Medical Research Future Fund. It’s run by MTPConnect –… Read more »
The Elite Robotics team: systems engineer Nathan Bartlett, industrial designer Luke De Bono and CEO Sahil Harriram. Photo: supplied The Hunter Valley, two hours north of Sydney, is best know for wine, horse breeding and coal mining. But it also has a burgeoning startup scene, with more than 50 startups backed up by more than… Read more »
Australian VC firm, Brandon Capital Partners, has just raised another $210 million to invest in commercialising medical research, and is already on the hunt for another $250 million as it edges towards $1 billion in science investments. The 5th Medical Research Commercialisation Fund, MRCF5, raised AU$210 million from existing investors, taking the total in the… Read more »
Two Australian scientists and startup founders will head to America’s prestigious Stanford University to study after impressing the CSIRO’s with their ideas during the organisation’s recent ON Accelerate program. Stephen Trowell, founder and MD of Parts Per Billion, and Melanie White, co-founder and director of Inova Medical, will receive $30,000 each towards travel and their… Read more »
Following the successful launch of Green Light, the world’s first algae biotech accelerator program in September 2018, applications for Round 2 are now open for NSW based small to medium sized enterprises (SMEs) and startups.
Startups in the wide-ranging Australian healthtech sector have raised more than a combined $165 million in funding, while biotech sits at $87.8 million.
Between bone repair glue and gene splicing, there is a diverse range of startups working to improve our health or innovate the way the sector operates.
Trimph is a biomedical startup working to commercialise a range of medical technologies using their patented polymer platform.
If you’re being bombarded with scam delivery messages, here’s why and what can be done
LinkedIn reveals who users think are the best Australian startups to work for, and tech ventures don’t rank highly
Steve Baxter’s syndicate VC TEN13 is on target to invest $100 million in just 3 years
Digital wealth management platform Tomorrow Super goes on the hunt for $5 million pre-IPO round
Daily startup news and insights, delivered to your inbox.
